(Reuters) – The following is a roundup of a number of the newest scientific research on the novel coronavirus and efforts to discover remedies and vaccines for COVID-19, the sickness attributable to the virus. FILE PHOTO: A medical employee vaccinates a person towards the coronavirus illness (COVID-19) as Israel kicks off a coronavirus vaccination drive, at Tel Aviv Sourasky Medical …

March 16 (Reuters) – Moderna Inc has begun dosing sufferers in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in youngsters aged six months to lower than 12 years, the corporate mentioned on Tuesday. The study will assess the protection and effectiveness of two doses of mRNA-1273 given 28 days aside and intends to enroll about 6,750 youngsters in …

FILE PHOTO: An NHS signal is displayed on the coronavirus illness (COVID-19) vaccination centre at Cliffs Pavilion in Southend-on-Sea, Britain, February 4, 2021. REUTERS/Paul Childs (Reuters) – NHS England has invited people aged 56 to 59 to book COVID-19 vaccinations in the coming week, with letters to 850,000 people in that age bracket touchdown on doorsteps from Saturday and one …

FILE PHOTO: A healthcare employee prepares a dose of the coronavirus illness (COVID-19) vaccine at a vaccination centre contained in the Blackburn Cathedral, in Blackburn, Britain, January 19, 2021. REUTERS/Molly Darlington/File Photo (Reuters) – The University of Oxford has launched a research to assess the protection and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in …

(Reuters) – Johnson & Johnson mentioned on Friday that its single-dose vaccine was 66% efficient in stopping COVID-19 in a big international trial in opposition to a number of variants, giving health officers one other weapon to sort out the pandemic. Vials with a sticker studying, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in …

(Reuters) – Drugmaker Merck & Co mentioned on Monday it could cease improvement of its two COVID-19 vaccines and focus pandemic analysis on remedies, with preliminary knowledge on an experimental oral antiviral anticipated by the tip of March. Merck was late to hitch the race to develop a vaccine to guard in opposition to the coronavirus, which has to this …

By Kate Kelland, Ludwig Burger LONDON/FRANKFURT (Reuters) – Pfizer and BioNTech have agreed to supply their COVID-19 vaccine to the World Health Organization co-led COVAX vaccine entry scheme, two sources conversant in the deal stated, the newest in a collection of photographs to be included within the mission aimed toward decrease-earnings international locations. The deal is predicted to be introduced …

By Laurence Frost, Jane Wardell PARIS/SYDNEY (Reuters) – The head of a world journey organisation on Monday opposed making COVID-19 vaccinations a requirement for travellers within the combat towards the pandemic, regardless of scepticism about reaching herd immunity this yr. Several health experts stated throughout the Reuters Next convention that the mass roll-out of coronavirus vaccines wouldn’t end in sufficient …

By Manas Mishra, Julie Steenhuysen FILE PHOTO: Medical workers member receives the Pfizer/BioNTech COVID-19 Vaccine at Jackson Memorial Hospital in Miami, Florida, U.S., December 15, 2020. REUTERS/Marco Bello (Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) stated on Wednesday it’s fastidiously monitoring allergic reactions to the coronavirus vaccines from Pfizer Inc and Moderna Inc and urged people …

By William Schomberg, Elizabeth Piper LONDON (Reuters) – British Prime Minister Boris Johnson on Monday ordered England into a new nationwide lockdown to comprise a surge in COVID-19 circumstances that threatens to overwhelm elements of the health system earlier than a vaccine programme reaches a vital mass. The announcement got here simply hours after the federal government hailed Britain’s success …